124 related articles for article (PubMed ID: 3583466)
21. [Features of the binding of the fluorescent probe K-35 to albumin].
Dobretsov GE; Syreĭshchikova TI; Gryzunov IuA; Smolina NV; Komar AA
Biofizika; 2010; 55(2):213-9. PubMed ID: 20429273
[TBL] [Abstract][Full Text] [Related]
22. [Binding of epirubicin to human plasma protein and erythrocytes: interaction with the cytoprotective amifostine].
Pernkopf I; Tesch G; Dempe K; Kletzl H; Schüller J; Czejka M
Pharmazie; 1996 Nov; 51(11):897-901. PubMed ID: 9036391
[TBL] [Abstract][Full Text] [Related]
23. Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.
Motoya T; Thevanayagam LN; Blaschke TF; Au S; Stone JA; Jayewardene AL; Chi J; Aweeka FT
HIV Med; 2006 Mar; 7(2):122-8. PubMed ID: 16420257
[TBL] [Abstract][Full Text] [Related]
24. Propofol binding to human blood proteins.
Altmayer P; Büch U; Büch HP
Arzneimittelforschung; 1995 Oct; 45(10):1053-6. PubMed ID: 8595056
[TBL] [Abstract][Full Text] [Related]
25. Stereoselective binding of isradipine to human plasma proteins.
Oravcová J; Sojková D; Bencsíková E; Bohov P; Trnovec T
Chirality; 1995; 7(3):167-72. PubMed ID: 7794694
[TBL] [Abstract][Full Text] [Related]
26. Phencyclidine blood protein binding: influence of protein, pH and species.
Owens SM; Mayersohn M; Woodworth JR
J Pharmacol Exp Ther; 1983 Sep; 226(3):656-60. PubMed ID: 6887006
[TBL] [Abstract][Full Text] [Related]
27. Enantioselective plasma protein binding of bimoclomol.
Visy J; Fitos I; Mády G; Urge L; Krajcsi P; Simonyi M
Chirality; 2002 Aug; 14(8):638-42. PubMed ID: 12125033
[TBL] [Abstract][Full Text] [Related]
28. gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.
Worms P; Depoortere H; Durand A; Morselli PL; Lloyd KG; Bartholini G
J Pharmacol Exp Ther; 1982 Mar; 220(3):660-71. PubMed ID: 6278129
[TBL] [Abstract][Full Text] [Related]
29. Theophylline protein binding.
Trnavská Z
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):166-9. PubMed ID: 2334456
[TBL] [Abstract][Full Text] [Related]
30. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
[TBL] [Abstract][Full Text] [Related]
31. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
[TBL] [Abstract][Full Text] [Related]
32. Specific and high affinity binding of perindoprilat, but not of perindopril to blood ACE.
Bree F; Nguyen P; Urien S; Resplandy G; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):325-30. PubMed ID: 1330941
[TBL] [Abstract][Full Text] [Related]
33. Cicletanine binding to human plasma proteins and erythrocytes, a particular HSA-drug interaction.
Zini R; Morin D; Jouenne P; Tillement JP
Life Sci; 1988; 43(25):2103-15. PubMed ID: 3210902
[TBL] [Abstract][Full Text] [Related]
34. [Protein binding of fenpentadiol-14C (2-méthyl-4-p-chlorophényl-2,4-pentane-diol) in vivo and in vitro (author's transl)].
Dormard Y; Plessas C; Benakis A
J Pharmacol; 1982; 13(1):11-20. PubMed ID: 6175856
[TBL] [Abstract][Full Text] [Related]
35. Effects of protein binding on the in vitro activity of antitumour acridine derivatives and related anticancer drugs.
Finlay GJ; Baguley BC
Cancer Chemother Pharmacol; 2000; 45(5):417-22. PubMed ID: 10803926
[TBL] [Abstract][Full Text] [Related]
36. Drug-protein interaction: plasma protein binding of furocoumarins.
Veronese FM; Bevilacqua R; Schiavon O; Rodighiero G
Farmaco Sci; 1979 Aug; 34(8):716-25. PubMed ID: 467637
[TBL] [Abstract][Full Text] [Related]
37. Binding of colchicine and thiocolchicoside to human serum proteins and blood cells.
Sabouraud A; Chappey O; Dupin T; Scherrmann JM
Int J Clin Pharmacol Ther; 1994 Aug; 32(8):429-32. PubMed ID: 7981928
[TBL] [Abstract][Full Text] [Related]
38. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
Morse DS; Abernethy DR; Greenblatt DJ
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
[TBL] [Abstract][Full Text] [Related]
39. Blood levels of progabide and its active metabolite in epileptic patients: relationships to the therapeutic outcome.
Benassi E; Morselli PL; Besio G; Bianchetti G; Loeb C
Int J Clin Pharmacol Res; 1988; 8(6):409-13. PubMed ID: 3253218
[TBL] [Abstract][Full Text] [Related]
40. Binedaline binding to plasma proteins and red blood cells in humans.
Morin D; Zini R; Ledewyn S; Colonna JP; Czajka M; Tillement JP
J Pharm Sci; 1985 Jul; 74(7):727-30. PubMed ID: 4032243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
